U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
86413
Name Type Language
ANGIOTENSIN 1-7
Common Name English
ANGIOTENSIN FRAGMENT 1-7
Common Name English
5-ILE-ANGIOTENSIN-(1-7)
Common Name English
TXA127
Code English
1-7-ANGIOTENSIN II, 5-L-ISOLEUCINE-
Common Name English
HUMAN ANGIOTENSIN II (1-7)
Common Name English
SH-HEPTAPEPTIDE-13 [INCI]
Common Name English
Angiotensin 1-7 [WHO-DD]
Common Name English
SH-HEPTAPEPTIDE-13
INCI  
INCI  
Official Name English
BF-ANGIOTENSIN 1-7
Brand Name English
TXA-127
Code English
ASP-ARG-VAL-TYR-ILE-HIS-PRO
Common Name English
ANGIOTENSIN PEPTIDE (1-7)
Common Name English
ANGIOTENSIN-(1-7)
Common Name English
ANGIOTENSIN (1-7)
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 144601
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 400813
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 308810
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 508815
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 546416
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 295809
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 129999
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
EU-Orphan Drug EU/3/12/1047
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 412313
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 411813
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 345411
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
FDA ORPHAN DRUG 402713
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
Code System Code Type Description
FDA UNII
IJ3FUK8MOF
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
PRIMARY
DRUG BANK
DB11720
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
PRIMARY
ChEMBL
CHEMBL3545347
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
PRIMARY
PUBCHEM
123805
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
PRIMARY
CHEBI
58922
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
PRIMARY
NCI_THESAURUS
C68962
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
PRIMARY
CAS
51833-78-4
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
PRIMARY
CHEBI
55438
Created by admin on Sat Dec 16 01:01:16 UTC 2023 , Edited by admin on Sat Dec 16 01:01:16 UTC 2023
PRIMARY
ACTIVE MOIETY
ANGIOTENSIN 1-7
SALT/SOLVATE (PARENT)
ANGIOTENSIN 1-7 ACETATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966